Gaugler J, James B, Johnson T, Reimer J, Solis M, Weuve J, Buckley RF, Hohman TJ (2022) 2022 Alzheimer’s disease facts and figures. Alzheimers & Dementia 18:700–789

Article  Google Scholar 

Qiu C, Kivipelto M, Von Strauss E (2009) Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11:111–128

Article  PubMed  PubMed Central  Google Scholar 

Perl DP (2010) Neuropathology of Alzheimer’s disease. Mount Sinai J Med 77:32–42

Article  Google Scholar 

DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener 14:32

Article  PubMed  PubMed Central  Google Scholar 

Golde TE (2023) Disease-modifying therapies for Alzheimer’s disease: more questions than answers. Neurotherapeutics 19:209–227

Article  Google Scholar 

Olivares D, Deshpande KV, Shi Y, Lahiri KD, Greig HN, Rogers TJ, Huang X (2012) N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer’s disease, vascular dementia and Parkinson’s disease. Curr Alzheimer Res 9:746–758

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z (2023) The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Med Res 28:544

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hershey LA, Tarawneh R (2021) Clinical efficacy, drug safety, and surrogate endpoints: has aducanumab met all of its expectations? In: AAN Enterprises, pp 517–518

Withington CG, Turner RS (2022) Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer’s disease. Front Neurol 13:862369

Article  PubMed  PubMed Central  Google Scholar 

Huang L-C, Yang Y-H (2022) The long-term effects of immersive virtual reality reminiscence in people with dementia: longitudinal observational study. JMIR Serious Games 10:e36720

Article  PubMed  PubMed Central  Google Scholar 

Zucchella C, Sinforiani E, Tamburin S, Federico A, Mantovani E, Bernini S, Casale R, Bartolo M (2018) The multidisciplinary approach to Alzheimer’s disease and dementia. A narrative review of non-pharmacological treatment. Front Neurol 9:1058

Article  PubMed  PubMed Central  Google Scholar 

Olazarán J, Reisberg B, Clare L, Cruz I, Peña-Casanova J, Del Ser T, Woods B, Beck C, Auer S, Lai C (2010) Nonpharmacological therapies in Alzheimer’s disease: a systematic review of efficacy. Dement Geriatr Cogn Disord 30:161–178

Article  PubMed  Google Scholar 

Wang L-Y, Pei J, Zhan Y-J, Cai Y-W (2020) Overview of meta-analyses of five non-pharmacological interventions for Alzheimer’s disease. Front Aging Neurosci 12:594432

Article  PubMed  PubMed Central  Google Scholar 

Buzsáki G, Wang X-J (2012) Mechanisms of gamma oscillations. Annu Rev Neurosci 35:203–225

Article  PubMed  PubMed Central  Google Scholar 

Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, Devidze N, Masliah E, Kreitzer AC, Mody I (2012) Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149:708–721

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mably AJ, Colgin LL (2018) Gamma oscillations in cognitive disorders. Curr Opin Neurobiol 52:182–187

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stam CJ, van Walsum AMVC, Pijnenburg YA, Berendse HW, de Munck JC, Scheltens P, van Dijk BW (2002) Generalized synchronization of MEG recordings in Alzheimer’s disease: evidence for involvement of the gamma band. J Clin Neurophysiol 19:562–574

Article  PubMed  Google Scholar 

König T, Prichep L, Dierks T, Hubl D, Wahlund LO, John ER, Jelic V (2005) Decreased EEG synchronization in Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 26:165–171

Article  Google Scholar 

McDermott B, Porter E, Hughes D, McGinley B, Lang M, O’Halloran M, Jones M (2018) Gamma band neural stimulation in humans and the promise of a new modality to prevent and treat Alzheimer’s disease. J Alzheimers Dis 65:363–392

Article  PubMed  PubMed Central  Google Scholar 

Adaikkan C, Tsai L-H (2020) Gamma entrainment: impact on neurocircuits, glia, and therapeutic opportunities. Trends Neurosci 43:24–41

Article  CAS  PubMed  Google Scholar 

Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, Mathys H, Seo J, Kritskiy O, Abdurrob F (2016) Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540:230–235

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adaikkan C, Middleton SJ, Marco A, Pao P-C, Mathys H, Kim DN-W, Gao F, Young JZ, Suk H-J, Boyden ES (2019) Gamma entrainment binds higher-order brain regions and offers neuroprotection. Neuron 102(929–943):e928

Google Scholar 

Martorell AJ, Paulson AL, Suk H-J, Abdurrob F, Drummond GT, Guan W, Young JZ, Kim DN-W, Kritskiy O, Barker SJ (2019) Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell 177(256–271):e222

Google Scholar 

Cimenser A, Hempel E, Travers T, Strozewski N, Martin K, Malchano Z, Hajós M (2021) Sensory-evoked 40-Hz gamma oscillation improves sleep and daily living activities in Alzheimer’s disease patients. Front Syst Neurosci 15:746859

Article  PubMed  PubMed Central  Google Scholar 

Chan D, Suk H-J, Jackson BL, Milman NP, Stark D, Klerman EB, Kitchener E, Avalos VSF, de Weck G, Banerjee A (2022) Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies. PLoS ONE 17:e0278412

Article  CAS  PubMed  PubMed Central  Google Scholar 

McNett SD, Vyshedskiy A, Savchenko A, Durakovic D, Heredia G, Cahn R, Kogan M (2023) A feasibility study of AlzLife 40 Hz sensory therapy in patients with MCI and early AD. In: Healthcare. MDPI, p 2040

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269

Article  PubMed  Google Scholar 

Chang Y-P, Chien C-F, Huang L-C, Chuu C-P, Chang H-W, Hour T-C, Yang Y-H (2024) White light stimulation at gamma frequency to modify the Aβ42 and tau proteins in SH-SY5Y cells. Am J Alzheimer’s Dis Other Dement 39:15333175241236252

Article  Google Scholar 

Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D (1994) The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6:45–58

Article  CAS  PubMed  Google Scholar 

Chiu E-C, Chien T-H, Lee Y-C (2021) Measurement equivalence between the original and estimated mini-mental state examination in people with dementia. Int J Environ Res Public Health 18:7616

Article  PubMed  PubMed Central  Google Scholar 

Morris JC (1993) The Clinical Dementia Rating (CDR) current version and scoring rules. Neurology 43:2412–2412-a

Article  CAS  PubMed  Google Scholar 

Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 12:233–239

Article  CAS  PubMed  Google Scholar 

Zarit SH, Orr NK, Zarit JM (1985) The hidden victims of Alzheimer’s disease: Families under stress. NYU press

Google Scholar 

Hébert R, Bravo G, Préville M (2000) Reliability, validity and reference values of the Zarit Burden Interview for assessing informal caregivers of community-dwelling older persons with dementia. Can J Aging/La Revue canadienne du vieillissement 19:494–507

Article  Google Scholar